Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Smoking cessation: benefits versus risks of using pharmacotherapy to quit.

Literature DB >> 24323794

Smoking cessation: benefits versus risks of using pharmacotherapy to quit.

Jonathan M Samet¹.

Abstract

Entities: Chemical Disease Species

Keywords: Editorials; pharmacology; smoking; smoking cessation

Mesh：

Substances：
Nicotinic Agonists

Year: 2013 PMID： 24323794 PMCID： PMC3917568 DOI： 10.1161/CIRCULATIONAHA.113.006928

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. Quitting smoking among adults--United States, 2001-2010.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2011-11-11 Impact factor: 17.586

2. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement.

Authors:
Journal: Ann Intern Med Date: 2009-04-21 Impact factor: 25.391

3. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Authors: Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett
Journal: Ann Intern Med Date: 2005-02-15 Impact factor: 25.391

4. Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

Authors: Benjamin J Apelberg; Georgiana Onicescu; Erika Avila-Tang; Jonathan M Samet
Journal: Am J Public Health Date: 2009-12-17 Impact factor: 9.308

5. Varenicline for smoking cessation.

Authors: Mira Harrison-Woolrych
Journal: BMJ Date: 2012-11-08

6. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors: R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal: Circulation Date: 2000-12-19 Impact factor: 29.690

Smoking cessation: benefits versus risks of using pharmacotherapy to quit.

1. Quitting smoking among adults--United States, 2001-2010.

2. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement.

3. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

4. Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

5. Varenicline for smoking cessation.

6. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

7. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Review 8. Cardiovascular effects of pharmacologic therapies for smoking cessation.

Review 9. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

10. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.